Cargando…
Use of mycophenolate mofetil in patients with pediatric and adult primary nephrotic syndrome: information from a Japanese hospital claims database
BACKGROUND: Current treatment for frequently relapsing, steroid-dependent, or steroid-resistant nephrotic syndrome focuses on immunosuppressive therapies. Although the clinical guideline suggests the use of mycophenolate mofetil (MMF), limited information is available on patients with primary nephro...
Autores principales: | Funatogawa, Takashi, Narita, Yusuke, Tamura, Aya, Mii, Kazuma, Sugitani, Yasuo, Uchida, Tomoaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481489/ https://www.ncbi.nlm.nih.gov/pubmed/35579722 http://dx.doi.org/10.1007/s10157-022-02233-w |
Ejemplares similares
-
Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome
por: Dorresteijn, Eiske M., et al.
Publicado: (2008) -
Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome
por: Al-Akash, Samhar, et al.
Publicado: (2005) -
Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children
por: Kang, Zhijuan, et al.
Publicado: (2015) -
Efficacy of Mycophenolate Mofetil as a Remission Maintaining Agent in Idiopathic Childhood Nephrotic Syndrome
por: Nandi, M., et al.
Publicado: (2019) -
A single-centre retrospective study of the safety and efficacy of mycophenolate mofetil in children and adolescents with nephrotic syndrome
por: Hassan, Akhila V., et al.
Publicado: (2013)